A district court had blocked laws prohibiting telemedicine abortions, ensuring second-trimester abortions only happen in hospitals or surgical centers, and requiring pregnant women be informed about fetal pain, among other things.
Acting FDA Commissioner Janet Woodcock declared it safe to allow mifepristone, the first half of the chemical abortion cocktail RU-486, to be taken home without medical supervision.